JP2013530156A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013530156A5 JP2013530156A5 JP2013512218A JP2013512218A JP2013530156A5 JP 2013530156 A5 JP2013530156 A5 JP 2013530156A5 JP 2013512218 A JP2013512218 A JP 2013512218A JP 2013512218 A JP2013512218 A JP 2013512218A JP 2013530156 A5 JP2013530156 A5 JP 2013530156A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cation exchange
- loading
- exchange material
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 58
- 239000000463 material Substances 0.000 claims description 49
- 238000005341 cation exchange Methods 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 26
- 239000000356 contaminant Substances 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 4
- 239000006167 equilibration buffer Substances 0.000 claims 6
- 239000012160 loading buffer Substances 0.000 claims 6
- 239000011534 wash buffer Substances 0.000 claims 6
- 229920002684 Sepharose Polymers 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- -1 sulfopropyl Chemical group 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 125000000524 functional group Chemical group 0.000 claims 2
- 241000699802 Cricetulus griseus Species 0.000 claims 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims 1
- 229930182566 Gentamicin Natural products 0.000 claims 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 1
- 238000005349 anion exchange Methods 0.000 claims 1
- 239000013018 capto adhere resin Substances 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000002843 carboxylic acid group Chemical group 0.000 claims 1
- 239000006143 cell culture medium Substances 0.000 claims 1
- 239000000919 ceramic Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229960002518 gentamicin Drugs 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 239000013019 capto adhere Substances 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34814310P | 2010-05-25 | 2010-05-25 | |
| US61/348,143 | 2010-05-25 | ||
| PCT/US2011/037977 WO2011150110A1 (en) | 2010-05-25 | 2011-05-25 | Methods of purifying polypeptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016093347A Division JP6272941B2 (ja) | 2010-05-25 | 2016-05-06 | ポリペプチドの精製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013530156A JP2013530156A (ja) | 2013-07-25 |
| JP2013530156A5 true JP2013530156A5 (enExample) | 2016-02-25 |
| JP5934190B2 JP5934190B2 (ja) | 2016-06-15 |
Family
ID=45004368
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013512218A Active JP5934190B2 (ja) | 2010-05-25 | 2011-05-25 | ポリペプチドの精製方法 |
| JP2016093347A Active JP6272941B2 (ja) | 2010-05-25 | 2016-05-06 | ポリペプチドの精製方法 |
| JP2018000140A Pending JP2018087192A (ja) | 2010-05-25 | 2018-01-04 | ポリペプチドの精製方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016093347A Active JP6272941B2 (ja) | 2010-05-25 | 2016-05-06 | ポリペプチドの精製方法 |
| JP2018000140A Pending JP2018087192A (ja) | 2010-05-25 | 2018-01-04 | ポリペプチドの精製方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (5) | US20130079272A1 (enExample) |
| EP (3) | EP3299380B1 (enExample) |
| JP (3) | JP5934190B2 (enExample) |
| KR (1) | KR101976853B1 (enExample) |
| CN (2) | CN107365346A (enExample) |
| AU (1) | AU2011258254B2 (enExample) |
| CA (2) | CA2799915C (enExample) |
| ES (2) | ES2991883T3 (enExample) |
| HK (1) | HK1246328A1 (enExample) |
| HR (2) | HRP20171095T4 (enExample) |
| HU (1) | HUE068857T2 (enExample) |
| IL (2) | IL223029A0 (enExample) |
| MX (2) | MX344248B (enExample) |
| MY (1) | MY161534A (enExample) |
| NZ (1) | NZ603648A (enExample) |
| PL (2) | PL3299380T3 (enExample) |
| RU (1) | RU2594163C2 (enExample) |
| SG (2) | SG185737A1 (enExample) |
| SI (1) | SI2575847T2 (enExample) |
| WO (1) | WO2011150110A1 (enExample) |
| ZA (1) | ZA201208673B (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY161534A (en) | 2010-05-25 | 2017-04-28 | Genentech Inc | Methods of purifying polypeptides |
| AU2012351751B2 (en) * | 2011-10-19 | 2017-09-07 | Novimmune S.A. | Methods of purifying antibodies |
| IL267585B (en) * | 2011-12-22 | 2022-09-01 | Genentech Inc | Ion exchange membrane chromatography |
| CN102911250B (zh) * | 2012-09-29 | 2014-04-16 | 浙江海正药业股份有限公司 | 酸性重组蛋白药物的纯化方法 |
| CN103880947B (zh) * | 2012-12-21 | 2016-01-13 | 武汉禾元生物科技股份有限公司 | 一种分离纯化高纯度重组人血清白蛋白的层析方法 |
| WO2014118685A2 (en) * | 2013-01-29 | 2014-08-07 | Dr. Reddy's Laboratories Limited | Method of altering the acidic variant content of antibody |
| EP2971087B1 (en) | 2013-03-14 | 2017-11-01 | Qiagen Sciences, LLC | Assessing dna quality using real-time pcr and ct values |
| CN104236983A (zh) * | 2013-06-14 | 2014-12-24 | 中国科学院大连化学物理研究所 | 溶液样品中含长烷基链的离子液体的去除方法 |
| EP3041593B1 (en) * | 2013-09-05 | 2025-01-29 | F. Hoffmann-La Roche AG | Method of cleaning a chromatography material for its reuse |
| CN105722532A (zh) | 2013-09-13 | 2016-06-29 | 豪夫迈·罗氏有限公司 | 包含纯化的重组多肽的方法和组合物 |
| BR112016004437A2 (pt) | 2013-09-13 | 2017-10-17 | Genentech Inc | métodos de imunoteste e de seleção de linhagem de células, anticorpos e kit |
| US10376582B2 (en) | 2013-10-16 | 2019-08-13 | Outlook Therapeutics, Inc. | Buffer formulations for enhanced antibody stability |
| US8859252B1 (en) | 2014-01-02 | 2014-10-14 | Aerial Biopharma, Llc | Prostatic acid phosphatase, compositions comprising the same, and methods for producing and/or purifying the same |
| WO2015105551A1 (en) * | 2014-01-09 | 2015-07-16 | Kentucky Bioprocessing, Inc. | Method of purifying monoclonal antibodies |
| PT3116891T (pt) | 2014-03-10 | 2020-05-18 | Richter Gedeon Nyrt | Purificação de imunoglobulina utilizando passos de pré-limpeza |
| EP3145950B1 (en) * | 2014-05-23 | 2019-01-09 | Instituto Massone S.A. | A process for obtaining hmg-up (human menopausal gonadotropin with ultra-purity grade) and a composition free of contaminants |
| US20170183376A1 (en) * | 2014-06-24 | 2017-06-29 | Insight Biopharmaceuticals Ltd. | Methods of purifying antibodies |
| GB201411802D0 (en) | 2014-07-02 | 2014-08-13 | Univ Bradford | Effervescent compositions |
| WO2016118707A1 (en) * | 2015-01-21 | 2016-07-28 | Oncobiologics, Inc. | Modulation of charge variants in a monoclonal antibody composition |
| AU2017213775A1 (en) | 2016-02-03 | 2018-08-16 | Outlook Therapeutics, Inc. | Buffer formulations for enhanced antibody stability |
| EP3472177B1 (en) | 2016-06-17 | 2024-08-14 | F. Hoffmann-La Roche AG | Purification of multispecific antibodies |
| CN109716127B (zh) | 2016-08-15 | 2022-06-14 | 豪夫迈·罗氏有限公司 | 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法 |
| JP6564539B1 (ja) | 2018-09-14 | 2019-08-21 | 長瀬産業株式会社 | スルホン酸化合物によるペプチド精製方法 |
| US20220002688A1 (en) * | 2018-12-20 | 2022-01-06 | Armagen, Inc. | Purification of iduronate-2-sulfatase immunoglobulin fusion protein |
| CN109765307B (zh) * | 2018-12-24 | 2021-06-29 | 山东省科学院海洋仪器仪表研究所 | 一种水体中六氯环己烷的测量方法 |
| CN111366547A (zh) * | 2018-12-26 | 2020-07-03 | 贵州中烟工业有限责任公司 | 一种用连续流动法测定烟草或烟草制品中α-氨基氮的检测方法 |
| TW202045527A (zh) | 2019-01-23 | 2020-12-16 | 日商第一三共股份有限公司 | 包含使用活性碳材料之步驟之抗體純化方法 |
| EP3962924A1 (en) | 2019-05-03 | 2022-03-09 | Genentech, Inc. | Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform |
| AR119264A1 (es) * | 2019-06-05 | 2021-12-09 | Genentech Inc | Método para reutilización de cromatografía |
| KR20220079844A (ko) * | 2019-10-14 | 2022-06-14 | 피어스 바이오테크놀로지, 인크 | 펩티드 정제 제제 및 방법 |
| CA3182940A1 (en) * | 2020-05-28 | 2021-12-02 | Kashiv Biosciences, Llc | An improved process of storing and preparing the protein formulation |
| US20230251269A1 (en) * | 2020-07-15 | 2023-08-10 | The Johns Hopkins University | Comprehensive analysis of anti-allergen antibodies using phage display |
| EP4237116A1 (en) * | 2020-10-30 | 2023-09-06 | Genentech, Inc. | Purification platforms for obtaining pharmaceutical compositions having a reduced hydrolytic enzyme activity rate |
| CN112852876B (zh) * | 2021-03-04 | 2022-11-29 | 西南大学 | 一种表达人表皮生长因子的家蚕丝腺重组表达载体及其制备方法和应用 |
| EP4314009A1 (en) | 2021-03-31 | 2024-02-07 | F. Hoffmann-La Roche AG | Purification of antibodies by mixed mode chromatography |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| DE3850542T2 (de) | 1987-09-23 | 1994-11-24 | Bristol Myers Squibb Co | Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen. |
| JPH04501201A (ja) | 1987-12-21 | 1992-03-05 | ジ・アップジョン・カンパニー | 発芽植物種子類のアグロバクテリウム媒介形質転換 |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| ATE144793T1 (de) | 1989-06-29 | 1996-11-15 | Medarex Inc | Bispezifische reagenzien für die aids-therapie |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| WO1992020373A1 (en) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| MX9204374A (es) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
| ATE419355T1 (de) | 1992-02-06 | 2009-01-15 | Novartis Vaccines & Diagnostic | Marker für krebs und biosynthetisches bindeprotein dafür |
| EP0626012B1 (en) | 1992-02-11 | 2003-07-09 | Cell Genesys, Inc. | Homogenotization of gene-targeting events |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| ATE149570T1 (de) | 1992-08-17 | 1997-03-15 | Genentech Inc | Bispezifische immunoadhesine |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| ES2091684T3 (es) | 1992-11-13 | 1996-11-01 | Idec Pharma Corp | Aplicacion terapeutica de anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de las celulas b. |
| CA2106612C (en) | 1993-09-21 | 2001-02-06 | Diana Pliura | Displacement chromatography process |
| US5545328A (en) * | 1993-09-21 | 1996-08-13 | Hemosol Inc. | Purification of hemoglobin by displacement chromatography |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US5712374A (en) | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
| US6592905B1 (en) * | 1996-01-31 | 2003-07-15 | Massey University | Production of an immunoglobulin enriched fraction from whey protein solutions |
| US6037454A (en) | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
| US20020032315A1 (en) | 1997-08-06 | 2002-03-14 | Manuel Baca | Anti-vegf antibodies |
| ATE321066T1 (de) | 1998-05-06 | 2006-04-15 | Genentech Inc | Anti-her2 antikörperzusammensetzung |
| JP4319979B2 (ja) | 2002-04-26 | 2009-08-26 | ジェネンテック・インコーポレーテッド | タンパク質の非アフィニティ精製 |
| SE526227C2 (sv) | 2002-05-15 | 2005-08-02 | North China Pharmaceutical Group | Metod för rening av rekombinant humant serumalbumin |
| EP1753455A2 (en) | 2004-06-04 | 2007-02-21 | Genentech, Inc. | Method for treating multiple sclerosis |
| WO2006031370A2 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| ES2579805T3 (es) | 2004-09-23 | 2016-08-16 | Genentech, Inc. | Anticuerpos y conjugados modificados por ingeniería genética con cisteína |
| WO2006043895A1 (en) | 2004-10-21 | 2006-04-27 | Ge Healthcare Bio-Sciences Ab | A method of antibody purification |
| KR101482791B1 (ko) | 2005-03-11 | 2015-01-21 | 와이어쓰 엘엘씨 | 약한 분배성 크로마토그래피법 |
| JP2008535913A (ja) * | 2005-04-11 | 2008-09-04 | メダレックス インコーポレーティッド | タンパク質精製方法 |
| DE112006001012B4 (de) | 2005-04-22 | 2017-05-18 | Waters Technologies Corp. (N.D.Ges.D. Staates Delaware) | Verfahren für eine auf Massenspektrometrie gerichtete Aufbereitung von Biopolymeren |
| US7691980B2 (en) | 2007-01-09 | 2010-04-06 | Bio-Rad Laboratories, Inc. | Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers |
| JP5361738B2 (ja) | 2007-01-22 | 2013-12-04 | ジェネンテック， インコーポレイテッド | 多価電解質沈殿物及びタンパク質の精製 |
| MX2009012786A (es) | 2007-06-01 | 2009-12-10 | Hoffmann La Roche | Purificacion de inmunoglobulina. |
| US9433922B2 (en) * | 2007-08-14 | 2016-09-06 | Emd Millipore Corporation | Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same |
| CL2008003218A1 (es) * | 2007-10-30 | 2009-03-06 | Genentech Inc | Método para la purificación de un anticuerpo a partir de una composición que comprende el anticuerpo y al menos un contaminante. |
| US8188242B2 (en) | 2008-04-08 | 2012-05-29 | Bio-Rad Laboratories, Inc. | Chromatography purification of antibodies |
| US20110105725A1 (en) | 2008-05-15 | 2011-05-05 | Novo Nordisk A/S | Antibody purification process |
| KR101843915B1 (ko) | 2008-08-14 | 2018-04-02 | 제넨테크, 인크. | 고유 단백질 대체 이온 교환 막 크로마토그래피를 이용한 오염물의 제거 방법 |
| EP2360183B1 (en) | 2008-12-19 | 2016-07-27 | Takeda Pharmaceutical Company Limited | Antibody purification method by mixed mode chromatography utilizing an arginine-containing loading solution |
| RU2011140486A (ru) * | 2009-03-06 | 2013-04-20 | МЕДИММЬЮН, ЭлЭлСи | Композиции, содержащие гуманизированные антитела к cd19 |
| CN102574911B (zh) | 2009-08-07 | 2017-06-06 | Emd密理博公司 | 从样品的一或多种杂质中纯化靶蛋白的方法 |
| WO2011035282A1 (en) | 2009-09-21 | 2011-03-24 | Ge Healthcare Bio-Sciences Ab | Dual capture separation |
| WO2011037983A1 (en) * | 2009-09-23 | 2011-03-31 | Medarex, Inc. | Cation exchange chromatography |
| MY161534A (en) | 2010-05-25 | 2017-04-28 | Genentech Inc | Methods of purifying polypeptides |
| WO2012068134A1 (en) | 2010-11-15 | 2012-05-24 | Biogen Idec Inc. | Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography |
-
2011
- 2011-05-25 MY MYPI2012005025A patent/MY161534A/en unknown
- 2011-05-25 NZ NZ603648A patent/NZ603648A/en unknown
- 2011-05-25 AU AU2011258254A patent/AU2011258254B2/en active Active
- 2011-05-25 MX MX2012013575A patent/MX344248B/es active IP Right Grant
- 2011-05-25 CA CA2799915A patent/CA2799915C/en active Active
- 2011-05-25 MX MX2016016228A patent/MX370828B/es unknown
- 2011-05-25 KR KR1020127033600A patent/KR101976853B1/ko active Active
- 2011-05-25 WO PCT/US2011/037977 patent/WO2011150110A1/en not_active Ceased
- 2011-05-25 EP EP17167800.6A patent/EP3299380B1/en active Active
- 2011-05-25 EP EP24189611.7A patent/EP4492053A3/en active Pending
- 2011-05-25 JP JP2013512218A patent/JP5934190B2/ja active Active
- 2011-05-25 SI SI201131267T patent/SI2575847T2/sl unknown
- 2011-05-25 HU HUE17167800A patent/HUE068857T2/hu unknown
- 2011-05-25 CN CN201710269454.2A patent/CN107365346A/zh active Pending
- 2011-05-25 PL PL17167800.6T patent/PL3299380T3/pl unknown
- 2011-05-25 HR HRP20171095TT patent/HRP20171095T4/hr unknown
- 2011-05-25 SG SG2012086419A patent/SG185737A1/en unknown
- 2011-05-25 ES ES17167800T patent/ES2991883T3/es active Active
- 2011-05-25 EP EP11787363.8A patent/EP2575847B2/en active Active
- 2011-05-25 PL PL11787363.8T patent/PL2575847T5/pl unknown
- 2011-05-25 HR HRP20241463TT patent/HRP20241463T1/hr unknown
- 2011-05-25 ES ES11787363T patent/ES2637613T5/es active Active
- 2011-05-25 CA CA3209878A patent/CA3209878A1/en active Pending
- 2011-05-25 SG SG10201710439UA patent/SG10201710439UA/en unknown
- 2011-05-25 CN CN2011800254040A patent/CN102905718A/zh active Pending
- 2011-05-25 RU RU2012156271/04A patent/RU2594163C2/ru active
-
2012
- 2012-11-14 IL IL223029A patent/IL223029A0/en active IP Right Grant
- 2012-11-19 ZA ZA2012/08673A patent/ZA201208673B/en unknown
- 2012-11-20 US US13/682,620 patent/US20130079272A1/en not_active Abandoned
-
2016
- 2016-05-06 JP JP2016093347A patent/JP6272941B2/ja active Active
-
2018
- 2018-01-04 JP JP2018000140A patent/JP2018087192A/ja active Pending
- 2018-05-08 HK HK18105945.5A patent/HK1246328A1/zh unknown
- 2018-08-14 IL IL261147A patent/IL261147A/en unknown
- 2018-10-22 US US16/167,364 patent/US20190300566A1/en not_active Abandoned
-
2020
- 2020-01-22 US US16/749,888 patent/US20200399307A1/en not_active Abandoned
-
2021
- 2021-07-07 US US17/369,765 patent/US12152054B2/en active Active
-
2024
- 2024-10-16 US US18/917,874 patent/US20250034204A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013530156A5 (enExample) | ||
| RU2012156271A (ru) | Способы очистки полипептидов | |
| JP2014532718A5 (enExample) | ||
| RU2014121884A (ru) | Хроматография перегрузки и элюирования | |
| TWI395609B (zh) | 免疫球蛋白之純化 | |
| TWI704155B (zh) | 雙特異性抗體之純化平台 | |
| TWI596107B (zh) | 單株抗體之新穎純化方法 | |
| RU2014121886A (ru) | Устройство для обработки курительного изделия и картридж для него | |
| TW201348247A (zh) | 利用蛋白質ａ親和性層析之非人類抗體之新穎純化 | |
| JP2011530592A5 (enExample) | ||
| JP2016026215A5 (enExample) | ||
| JP2014520814A5 (enExample) | ||
| CA2930350A1 (en) | Immunoglobulin purification using pre-cleaning steps | |
| HRP20150282T4 (hr) | Purifikacija protutijela pomoću kromatografije kationskom izmjenom | |
| CN107188960A (zh) | 从样品的一或多种杂质中纯化靶蛋白的方法 | |
| JP2013517318A (ja) | Ｆｃ含有タンパク質を精製するためのクロマトグラフィー法 | |
| JP2018510867A5 (enExample) | ||
| TWI853823B (zh) | 自混合物製備多肽之系統及方法 | |
| JP2016530236A5 (enExample) | ||
| JP2016531581A5 (enExample) | ||
| JP2025090586A (ja) | クロマトグラフィーの使用および再生のためのシステムおよび方法 | |
| Goodarzi et al. | Determining buffer conditions for downstream processing of VLP-based recombinant hepatitis B surface antigen using multimodal resins in bind-elute and flow-through purification modes | |
| CN113747960A (zh) | 用于再生色谱树脂的方法 | |
| Zhang et al. | Development of an automated mid-scale parallel protein purification system for antibody purification and affinity chromatography | |
| TW202003555A (zh) | 用於純化重組多肽之方法 |